Axe Compute Inc. Common Stock AGPU Business Segments
| TTM Q1 '25 | ||
|---|---|---|
| Revenue (Gross) by Business | ||
| Compute Services And Treasury Management | $0— | |
| Drug Discovery Services | $173.92K— | |
| Net Income Loss Excluding Discontinued Operations by Business | ||
| Compute Services And Treasury Management | $0— | |
| Drug Discovery Services | -$4.06M— | |
| Operating Income by Business | ||
| Compute Services And Treasury Management | $0— | |
| Drug Discovery Services | -$4.06M— | |
| Cost of Goods Sold by Business | ||
| Compute Services And Treasury Management | $0— | |
| Drug Discovery Services | $1.04M— | |
| Segment Expenditure Addition To Long Lived Assets by Business | ||
| Compute Services And Treasury Management | $0— | |
| Drug Discovery Services | $2.27K— | |
| Depreciation And Amortization by Business | ||
| Compute Services And Treasury Management | $0— | |
| Drug Discovery Services | $214.97K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Axe Compute Inc. Common Stock break its business down?
- Axe Compute Inc. Common Stock (AGPU) reports revenue (gross) by business across 2 parts — Compute Services And Treasury Management and Drug Discovery Services. Each is extracted from the segment footnotes and tracked over time.
- Where does Axe Compute Inc. Common Stock's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Axe Compute Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
